Tamoxifen suppresses nlrp3 priming via mir-223 in breast cancer independently from erα

Hamza, ShaimaaGaranina, Ekaterina E.Khaiboullina, Svetlana F.2024-09-092024-09-092022-12-15https://hdl.handle.net/11452/44390eninfo:eu-repo/semantics/closedAccessScience & technologyLife sciences & biomedicineCell biologyTamoxifen suppresses nlrp3 priming via mir-223 in breast cancer independently from erαMeeting Abstract000936399600005228